RISE Life Science Corp. operates through its two wholly owned subsidiaries - Scout Assessment Corp. and Jamaica BLU Limited. Scout Assessment Corp.’s key product is the Scout DS®, a device that has been regulatory cleared in certain markets both as a non-invasive clinical tool to assist in the identification of both prediabetes and type 2 diabetes. Jamaica BLU Limited holds the exclusive Canadian licence of all current and future cannabis commercial products developed by Rise Research Inc. Currently, Rise Research’s portfolio consists of cannabis-based formulations which support patients with low libido called Jamaica blū and Jamaica pnk.
The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.